Nuburu, Inc. - BURU STOCK NEWS

NUBURU, Inc. (OTC: BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, has announced that NYSE American has resolved the company's continued listing deficiency related to low selling price. As a result, NYSE Regulation has withdrawn its delisting determination and will lift the trading suspension on NUBURU's common stock. Trading will resume on NYSE American on Friday, August 2, 2024, under the symbol 'BURU' and CUSIP '67021W301'. This development marks a significant turnaround for NUBURU, addressing concerns about its listing status and potentially improving its market visibility and liquidity.

NUBURU (OTC: BURU), a leader in high-power industrial blue laser technology, has announced a strategic marketing partnership with NexGenAI Solutions Group. This collaboration aims to enhance NUBURU's marketing efforts using advanced AI and proprietary tools to drive commercial growth and market penetration.

NexGenAI's expertise in AI-driven marketing solutions will provide NUBURU with deep market insights and enable targeted campaigns. The partnership is expected to streamline NUBURU's marketing processes and improve customer engagement in key markets.

Brian Knaley, CEO of NUBURU, expressed excitement about the collaboration, emphasizing the importance of AI-driven solutions in identifying and connecting with customers. Anshuman Dash, President of NexGenAI, affirmed their commitment to supporting NUBURU's marketing initiatives and achieving significant market impact.

NUBURU, Inc. (OTC: BURU), a leader in high-power industrial blue laser technology, has announced a revised date for its 1-for-40 reverse stock split. The new record date is set for July 23, 2024, with trading on a split-adjusted basis expected to begin on July 24, 2024. CEO Brian Knaley stated that this strategic move aims to pursue resuming trading on NYSE and attract larger investors. The company's stock will continue trading under the symbol 'BURU' but will be assigned a new CUSIP number. However, NUBURU cautions that there's no guarantee of sustained stock price increase or successful relisting on NYSE American.

NUBURU (OTC: BURU), a leading innovator in high-power, high-brightness industrial blue laser technology, has announced a multi-part TV series featuring CEO Brian Knaley on FMW Media’s “New To The Street” business TV show. The initial interview will air on July 3, covering topics like NUBURU’s value proposition, strategic reverse split, recent commercial traction, debt reduction, and contracts with NASA. This initiative aims to enhance communication with investors and support the company's growth strategy. The series will be broadcast on major networks including Fox Business, Bloomberg TV, and Newsmax TV.

NUBURU (OTC: BURU), a leading innovator in high-power blue laser technology, announced a revised date for its 1-for-40 reverse stock split. Originally scheduled for July 1, 2024, the new date is set for July 10, 2024. This strategic move aims to help the company resume trading on the NYSE and attract larger investors. The reverse split will be effective after market close on July 10, with trading on a split-adjusted basis starting July 11, 2024. The stock will retain its current trading symbol but will receive a new CUSIP number, 67021W301. However, there are no guarantees that the trading price will increase or remain sustained, nor that the company will successfully resume trading on the NYSE.

NUBURU, a leading innovator in industrial blue laser technology, announced a 1-for-40 reverse stock split of its common stock, aiming for July 1, 2024, to improve marketability and liquidity. Initially planned for June 24, 2024, the split was delayed due to NYSE halting trading on the first announcement. NUBURU is appealing the NYSE's decision to delist its stock, currently traded over-the-counter as 'BURU'. Post-split, the stock will trade under the same symbol with a new CUSIP number, 67021W301. CEO Brian Knaley emphasized the move's strategic importance for attracting institutional investors and returning to NYSE American. However, the success of the appeal and meeting NYSE's bid price requirements remain uncertain, potentially impacting liquidity, market price, and the ability to raise equity financing.

NUBURU, a leader in industrial blue laser technology, has announced plans to appeal the NYSE's decision to delist its common stock. The NYSE cited that the company's stock is no longer suitable for listing as its bid price fell below $0.10, in accordance with Section 1003(f)(v) of the NYSE American Company Guide. Effective June 14, 2024, FINRA has assigned the symbol “BURU” for NUBURU's stock to be traded in the over-the-counter (OTC) market. CEO Brian Knaley emphasized the company's ongoing efforts to reduce debt, raise capital, secure new orders, and receive industry recognitions despite the delisting notice. NUBURU remains committed to strengthening relationships with shareholders, financing partners, employees, customers, and vendors to enhance its business plan and increase shareholder value.

NUBURU, a leader in high-power blue laser technology, shared a letter from CEO Brian Knaley outlining strategic realignments and growth milestones. The company has increased orders, reduced debt by 25%, and plans a 1-for-40 reverse stock split effective June 24, 2024, to maintain NYSE listing and appeal to institutional investors. NUBURU holds over 220 patents and continues to innovate with products like the AO-650 and BL series lasers. The company is focused on reducing carbon emissions and improving manufacturing efficiency. Future plans include expanding their workforce and investing in R&D to maintain industry leadership and open new markets.

NUBURU has received a purchase order from Blueacre Technology, a European medical device manufacturer, for its BlueScan solution. The blue laser technology will be used for precision welding in medical devices, leveraging its ability to work with various metals and reduce heat damage. This move expands NUBURU's market focus beyond electric vehicles to include medical devices, a sector worth $6 billion. The order follows NUBURU's Phase II contract with NASA to advance blue laser power transmission technology for space applications.